Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Restylane Kysse
- Development stage
- Unknown
- Lead developer
- Galderma
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intradermal
01
Overview
Restylane Kysse is a sterile, biodegradable, viscoelastic gel composed of crosslinked hyaluronic acid (HA) of bacterial origin and lidocaine hydrochloride. It is designed for injection into the lips to augment lip volume and correct upper perioral rhytids (wrinkles above the mouth) in adults over 21 years old. The product uses XpresHAn Technology (also known as Optimal Balance Technology), which allows for advanced tissue integration to achieve natural-looking results with flexibility and structure. The HA concentration is 20 mg/mL in phosphate buffered saline at pH 7, with 3 mg/mL lidocaine hydrochloride added for local anesthesia during injection. Results are clinically proven to last up to one year[1][2][4][5]. Developed by Galderma, it was previously marketed as Emervel Lips Lidocaine in some regions.
- Brand names
- Restylane KysseEmervel Lips Lidocaine
- Other names
- Restylane KysseEmervel Lips Lidocaine
02
Targets
ECF (Extracellular fluid)
Beyond the preview
Go deeper on Restylane Kysse.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Restylane Kysse.